Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Full Paper
  • Published:

Is there an interaction between interleukin-10 and interleukin-22?

Abstract

Interleukin(IL)-10 and IL-22 are structurally related cytokines. Their heterodimeric receptors consist of the cytokine-specific chains IL-10R1 and IL-22R1, respectively, and the common chain IL-10R2. This study focused on the question of whether IL-10 modulates IL-22 effects and vice versa. This question is important because IL-10 and IL-22 exert anti- and proinflammatory effects, respectively, and, as we show here, are simultaneously present in both systemic and local inflammation. The revealed lacking concomitance of IL-10R1 and IL-22R1 on identical cells excluded any possible interaction between IL-10 and IL-22 apart from the competition for IL-10R2. To study this competition, monocytes and hepatocytes were chosen. The dependence of the cytokine action on IL-10R2 was verified. Interestingly, no influence of IL-22 on IL-10 effects was observed. The same was true when IL-22 was used in complex with IL-22-binding protein. Similarly, no influence of IL-10 was found on IL-22 action. This missing competition seemed to be due to a lack of binding between IL-10R2 and the native cytokines in the absence of their corresponding R1 chain. However, IL-10R2 interacted with defined IL-10- and IL-22-derived peptides supporting the hypothesis that cytokine binding to its corresponding R1 chain creates a binding site on this cytokine for IL-10R2.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A . Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683–765.

    Article  CAS  PubMed  Google Scholar 

  2. Fiorentino DF, Bond MW, Mosmann TR . Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081–2095.

    Article  CAS  PubMed  Google Scholar 

  3. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE . Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209–1220.

    Article  CAS  PubMed  Google Scholar 

  4. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A . IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815–3822.

    CAS  PubMed  Google Scholar 

  5. de Waal Malefyt R, Haanen J, Spits H et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991; 174: 915–924.

    Article  CAS  PubMed  Google Scholar 

  6. Willems F, Marchant A, Delville JP et al. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 1994; 24: 1007–1009.

    Article  CAS  PubMed  Google Scholar 

  7. Berkman N, John M, Roesems G, Jose PJ, Barnes PJ, Chung KF . Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages. J Immunol 1995; 155: 4412–4418.

    CAS  PubMed  Google Scholar 

  8. Marfaing-Koka A, Maravic M, Humbert M, Galanaud P, Emilie D . Contrasting effects of IL-4, IL-10 and corticosteroids on RANTES production by human monocytes. Int Immunol 1996; 8: 1587–1594.

    Article  CAS  PubMed  Google Scholar 

  9. Kopydlowski KM, Salkowski CA, Cody MJ et al. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J Immunol 1999; 163: 1537–1544.

    CAS  PubMed  Google Scholar 

  10. te Velde AA, de Waal Malefijt R, Huijbens RJ, de Vries JE, Figdor CG . IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. J Immunol 1992; 149: 4048–4052.

    CAS  PubMed  Google Scholar 

  11. Ho AS, Liu Y, Khan TA, Hsu DH, Bazan JF, Moore KW . A receptor for interleukin 10 is related to interferon receptors. Proc Natl Acad Sci USA 1993; 90: 11267–11271.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kotenko SV, Krause CD, Izotova LS, Pollack BP, Wu W, Pestka S . Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J 1997; 16: 5894–5903.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Finbloom DS, Winestock KD . IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J Immunol 1995; 155: 1079–1090.

    CAS  PubMed  Google Scholar 

  14. Wehinger J, Gouilleux F, Groner B, Finke J, Mertelsmann R, Weber-Nordt RM . IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Lett 1996; 394: 365–370.

    Article  CAS  PubMed  Google Scholar 

  15. Volk H, Asadullah K, Gallagher G, Sabat R, Grutz G . IL-10 and its homologs: important immune mediators and emerging immunotherapeutic targets. Trends Immunol 2001; 22: 414–417.

    Article  CAS  PubMed  Google Scholar 

  16. Renauld JC . Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat Rev Immunol 2003; 3: 667–676.

    Article  CAS  PubMed  Google Scholar 

  17. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB . Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004; 22: 929–979.

    Article  CAS  PubMed  Google Scholar 

  18. Dumoutier L, Louahed J, Renauld JC . Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 2000; 164: 1814–1819.

    Article  CAS  PubMed  Google Scholar 

  19. Wolk K, Kunz S, Asadullah K, Sabat R . Cutting edge: immune cells as sources and targets of the IL-10 family members? J Immunol 2002; 168: 5397–5402.

    Article  CAS  PubMed  Google Scholar 

  20. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R . IL-22 increases the innate immunity of tissues. Immunity 2004; 21: 241–254.

    Article  CAS  PubMed  Google Scholar 

  21. Dumoutier L, Van Roost E, Colau D, Renauld JC . Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci USA 2000; 97: 10144–10149.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Radaeva S, Sun R, Pan HN, Hong F, Gao B . Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 2004; 39: 1332–1342.

    Article  CAS  PubMed  Google Scholar 

  23. Aggarwal S, Xie MH, Maruoka M, Foster J, Gurney AL . Acinar cells of the pancreas are a target of interleukin-22. J Interferon Cytokine Res 2001; 21: 1047–1053.

    Article  CAS  PubMed  Google Scholar 

  24. Xie MH, Aggarwal S, Ho WH et al. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 2000; 275: 31335–31339.

    Article  CAS  PubMed  Google Scholar 

  25. Kotenko SV, Izotova LS, Mirochnitchenko OV et al. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol Chem 2001; 276: 2725–2732.

    Article  CAS  PubMed  Google Scholar 

  26. Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ, Renauld JC . Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem 2002; 277: 33676–33682.

    Article  CAS  PubMed  Google Scholar 

  27. Dumoutier L, Lejeune D, Colau D, Renauld JC . Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22. J Immunol 2001; 166: 7090–7095.

    Article  CAS  PubMed  Google Scholar 

  28. Kotenko SV, Izotova LS, Mirochnitchenko OV et al. Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J Immunol 2001; 166: 7096–7103.

    Article  CAS  PubMed  Google Scholar 

  29. Xu W, Presnell SR, Parrish-Novak J et al. A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc Natl Acad Sci USA 2001; 98: 9511–9516.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Gruenberg BH, Schoenemeyer A, Weiss B et al. A novel, soluble homologue of the human IL-10 receptor with preferential expression in placenta. Genes Immun 2001; 2: 329–334.

    Article  CAS  PubMed  Google Scholar 

  31. Dumoutier L, Leemans C, Lejeune D, Kotenko SV, Renauld JC . Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types. J Immunol 2001; 167: 3545–3549.

    Article  CAS  PubMed  Google Scholar 

  32. Parrish-Novak J, Xu W, Brender T et al. Interleukins 19, 20, and 24 signal through two distinct receptor complexes. Differences in receptor-ligand interactions mediate unique biological functions. J Biol Chem 2002; 277: 47517–47523.

    Article  CAS  PubMed  Google Scholar 

  33. Sheppard P, Kindsvogel W, Xu W et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 2003; 4: 63–68.

    Article  CAS  PubMed  Google Scholar 

  34. Kotenko SV, Gallagher G, Baurin VV et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003; 4: 69–77.

    Article  CAS  PubMed  Google Scholar 

  35. Sheikh F, Baurin VV, Lewis-Antes A et al. Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2. J Immunol 2004; 172: 2006–2010.

    Article  CAS  PubMed  Google Scholar 

  36. Josephson K, Logsdon NJ, Walter MR . Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site. Immunity 2001; 15: 35–46.

    Article  CAS  PubMed  Google Scholar 

  37. Reineke U, Sabat R, Volk HD, Schneider-Mergener J . Mapping of the interleukin-10/interleukin-10 receptor combining site. Protein Sci 1998; 7: 951–960.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Nagem RA, Colau D, Dumoutier L, Renauld JC, Ogata C, Polikarpov I . Crystal structure of recombinant human interleukin-22. Structure (Camb) 2002; 10: 1051–1062.

    Article  CAS  Google Scholar 

  39. Reineke U, Schneider-Mergener J, Glaser RW et al. Evidence for conformationally different states of interleukin-10: binding of a neutralizing antibody enhances accessibility of a hidden epitope. J Mol Recognit 1999; 12: 242–248.

    Article  CAS  PubMed  Google Scholar 

  40. Logsdon NJ, Jones BC, Josephson K, Cook J, Walter MR . Comparison of interleukin-22 and interleukin-10 soluble receptor complexes. J Interferon Cytokine Res 2002; 22: 1099–1112.

    Article  CAS  PubMed  Google Scholar 

  41. Pletnev S, Magracheva E, Kozlov S et al. Characterization of the recombinant extracellular domains of human interleukin-20 receptors and their complexes with interleukin-19 and interleukin-20. Biochemistry 2003; 42: 12617–12624.

    Article  CAS  PubMed  Google Scholar 

  42. Li J, Tomkinson KN, Tan XY et al. Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2. Int Immunopharmacol 2004; 4: 693–708.

    Article  CAS  PubMed  Google Scholar 

  43. Walter MR, Windsor WT, Nagabhushan TL et al. Crystal structure of a complex between interferon-gamma and its soluble high-affinity receptor. Nature 1995; 376: 230–235.

    Article  CAS  PubMed  Google Scholar 

  44. Wolk K, Docke WD, von Baehr V, Volk HD, Sabat R . Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000; 96: 218–223.

    CAS  PubMed  Google Scholar 

  45. Reineke U . Antibody epitope mapping using arrays of synthetic peptides. Methods Mol Biol 2004; 248: 443–463.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Annette Buβ, Christa Liebenthal, and Michaela Nieter for excellent technical assistance. We also thank Elizabeth Wallace for accurately proofreading the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R Sabat.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wolk, K., Witte, E., Reineke, U. et al. Is there an interaction between interleukin-10 and interleukin-22?. Genes Immun 6, 8–18 (2005). https://doi.org/10.1038/sj.gene.6364144

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gene.6364144

Keywords

This article is cited by

Search

Quick links